FOIA Number: DOJ-18-0450

Rejection from DOJ Executive Office for U.S. Attorneys Regarding Communications with Rudy Giuliani about Opioids

October 9, 2018
Rejection from the Executive Office for United States Attorneys in response to American Oversight's requests for DOJ communications with Rudy Giuliani about opioids.

Watchdog Demands Records on Rudy Giuliani’s Past Consulting for OxyContin Manufacturer

August 24, 2018
American Oversight today demanded the release of records to uncover the role that Rudy Giuliani may have played in quashing federal investigations into Purdue Pharma, the manufacturer of the powerful prescription opioid OxyContin. In the early 2000s, Purdue worked with Giuliani’s consulting firm while Giuliani served as a consultant to the Justice Department (DOJ) on opioid issues and fundraised for a museum honoring the Drug Enforcement Administration

FOIA to DOJ Regarding For Communications with Giuliani Regarding Opioids

August 24, 2018
FOIA to DOJ seeking communications between senior DOJ appointees and Rudy Giuliani or Purdue Pharma between 2002-2008.